Biolife Solutions (BLFS) Shares Outstanding (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Shares Outstanding (Entity) data on file, last reported at $48.8 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.69% year-over-year to $48.8 million in Q1 2026; TTM through Mar 2026 was $48.8 million, a 2.69% increase from a year earlier, with the FY2025 full-year figure at $48.2 million, up 2.75% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $48.8 million, up from $48.2 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for BLFS reached as high as $48.8 million in Q1 2026 and fell as low as $42.3 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $45.4 million across 5 years, with a median of $45.7 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) increased 25.86% in 2022 and climbed 2.13% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $42.8 million in 2022, then advanced by 5.45% to $45.2 million in 2023, then increased by 3.85% to $46.9 million in 2024, then gained by 2.75% to $48.2 million in 2025, then rose by 1.3% to $48.8 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $48.8 million in Q1 2026, $48.2 million in Q4 2025, and $48.0 million in Q3 2025.